804
Participants
Start Date
November 3, 2021
Primary Completion Date
October 2, 2024
Study Completion Date
October 2, 2024
Simufilam
Simufilam is a novel drug candidate designed to treat and slow the progression of AD. Simufilam binds with femtomolar affinity to an altered conformation of filamin A that is present in the brain of patients with AD and critical to the toxicity of Aβ42. In this study, simufilam will be given b.i.d. for 52 weeks at a dose of 100 mg.
Placebo
Matching placebo given b.i.d. for 52 weeks.
KaRa MINDS, Macquarie Park
The Alfred Hospital, Melbourne
Royal Melbourne Hospital, Parkville
Austin Health, Heidelberg
Eastern Health, Box Hill
Delmont Private Hospital, Glen Iris
The University of Queensland, Herston
Impact Health Pty Ltd., Southport
Australian Alzheimer's Research Foundation, Nedlands
NY Neurology Associates, New York
Five Town Neuroscience Research, Woodmere
Mid Hudson Medical Research, New Windsor
Dent Neurologic Institute, Amherst
University of Rochester Medical Center - Alzheimer's Disease Care, Research and Education Program, Rochester
Global Medical Institutes/Scranton Medical Institute - Moosic Division, Moosic
Brian Abaluck, LLC, Malvern
Re:Cognition Health, Fairfax
Triad Clinical Trials, LLC, Greensboro
Alzheimer's Memory Center, Matthew
Palmetto Clinical Research, Summerville
Arrow Clinical Trials, Daytona Beach
Progressive Medical Research, Port Orange
Charter Research, Lady Lake
CNS Healthcare - Jacksonville, Jacksonville
Topaz Clinical Research, Apopka
ClinCloud, Maitland
Charter Research, Orlando
Combined Research Orlando Phase I-IV, Orlando
Merritt Island Medical Research, LLC, Merritt Island
Velocity Clinical Research, Hallandale Beach, Hallandale
Galiz Research, Hialeah
Infinity Clinical Research - Sunrise, Hollywood
Central Miami Medical Institute (GMI), Miami
Quantam Clinical Trials, Miami Beach
New Horizon Research Center, Miami
South Florida Research Phase I-IV INC, Miami Springs
Luminous Clinical Research, Miami
Segal Trials - West Broward Outpatient Site, Lauderhill
Premier Research Institute at Palm Beach Neurology, West Palm Beach
Neurology Offices of South Florida, Boca Raton
Boynton Beach Medical Research Institute (GMI), Boynton Beach
Clinical Research of Brandon, LLC (Tampa), Tampa
Stedman Clinical Trials, Tampa
Neuropsychiatric Research Center of Southwest Florida, Fort Myers
Renstar Medical Research, Ocala
Suncoast Clinical Research, Inc., New Port Richey
K2 Medical Research - Clermont, Clermont
Insight Clinical Trials LLC, Beachwood
NeuroScience Research Center, LLC, Canton
Dayton Center for Neurological Disorders, Centerville
Northwestern Medicine Central DuPage Hospital, Winfield
Clinical Research Professionals, Chesterfield
Ascension Via Christi Research, Wichita
CCT Research - Papillion Research Center, Papillion
Neuro Medical Clinic of Central Louisiana, LLC, Alexandria
Texas Neurology, PA, Dallas
Baylor Scott & White Research Institute, Dallas
Grayline Research Center, Wichita Falls
Mt. Olympus Medical Research, LLC, Katy
FutureSearch Trials of Neurology, Austin
Senior Adults Specialty Research, Inc, Austin
Colorado Neurological Research Center, PC, Denver
Mountain Neurological Research Center, Basalt
Velocity Clinical Research, Boise, Meridian
Xenoscience, Inc., Phoenix
MDFirst Research, Chandler
CCT Research - Gilbert Neurology Partners, Gilbert
Albuquerque Neuroscience, Inc, Albuquerque
Sun Valley Research Center, Inc., Imperial
Axiom Research, LLC, Colton
Artemis Institute for Clinical Research, Riverside
ATP Clinical Research, Inc., Costa Mesa
Senior Clinical Trials, Laguna Hills
Syrentis Clinical Research, Santa Ana
Advanced Research Center, Inc, Anaheim
Summit Research Network, LLC, Portland
Memory and Brain Wellness Center at Harborview, Seattle
CT Clinical Research, Cromwell
Boston Neuro Research Center, North Dartmouth
Advanced Clinical Institute, Inc, West Long Branch
Parker Jewish Institute for Health Care & Rehabilitation, New Hyde Park
Rhode Island Mood & Memory Research Institute, East Providence
Green Mountain Research Institute, Inc., Rutland
LMC Clinical Research - London, London
Bluewater Clinical Research Group Inc, Sarnia
Q & T Research, Sherbrooke
Diex Research Sherbrooke Inc., Sherbrooke
Alpha Recherche Clinique, Québec
Lead Sponsor
Collaborators (1)
Premier Research Group plc
UNKNOWN
Cassava Sciences, Inc.
INDUSTRY